Company Snapshot: BPUR  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services

Biopure Moves to Nasdaq Capital Market
 
    CAMBRIDGE, Mass., April 20 /PRNewswire-FirstCall/ -- Biopure
Corporation (Nasdaq: BPUR) today announced that The Nasdaq Stock Market has
approved the company's application to transfer the listing of its common
stock from The Nasdaq Global Market to The Nasdaq Capital Market. Biopure
expects trading of its stock on the Nasdaq Capital Market to begin on
Monday, April 23, 2007, under its existing symbol, BPUR.
    Biopure Corporation develops, manufactures and markets pharmaceuticals,
called oxygen therapeutics, that are intravenously administered to deliver
oxygen to the body's tissues.
    Contact:  Douglas Sayles             Herb Lanzet (Investors)
              Biopure Corporation        H.L. Lanzet Inc.
              (617) 234-6826             (212) 888-4570
              IR@biopure.com             lanzet@aol.com
SOURCE Biopure Corporation



Back to Topback to top

Related links:
  • http://www.biopure.com/
  • http://www.prnewswire.com/comp/131224.html /
    CONTACT:
    Douglas Sayles of Biopure Corporation,
    +1-617-234-6826, IR@biopure.com ; or Investors, Herb Lanzet of
    H.L. Lanzet Inc., +1-212-888-4570, lanzet@aol.com, for Biopure
    Corporation
    www.technorati.com Blogs Linking to this News Release at Technorati
    Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
    Terms and conditions, including restrictions on redistribution, apply.
    Copyright © 1996- PR Newswire Association LLC. All Rights Reserved.
    A United Business Media company.